macular degeneration and diabetes center logo
happy older woman after LUCENTIS treatment

Lucentis

LUCENTIS® (ranibizumab injection) is an FDA-approved prescription medicine for the treatment of patients with wet age-related macular degeneration (AMD). It is a breakthrough treatment that can do more than just help you maintain your vision. With LUCENTIS, people with wet AMD may see their vision improve or keep the vision they have.
  • Up to 40% of patients had a significant improvement of at least 3 more lines (15 letters) on the eye chart.
  • 70% of patients could see at least 1 more letter on the eye chart.
  • 95% of patients had their eyesight stay the same (lost fewer than 15 letters or 3 lines).
  • Up to 40% of patients achieved vision of 20/40 or better.
Request a Consultation
Contact Us

Florida Eye Institute is OPEN for all Services & Surgery

We’re taking extra precautions to protect you during the current COVID pandemic.

Be assured that we are actively implementing recommendations from the CDC and Florida Department of Health to ensure everyone’s safety during this extraordinary time. 

• temperature checks for patients and staff entering the facility
• reduced waiting room capacity for social distancing
• enhanced cleaning procedures
• masks for employees in patient care areas
• patients required to wear their own personal facial covering while inside the facility
• only patients allowed to enter the facility; drivers and family are asked to wait outside
• telehealth appointments available for many conditions

We are happy to welcome you back!